TELO Latest Press Releases

-- September 17, 2026 --

Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD) Globe Newswire 8:30 AM

-- September 14, 2026 --

Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models Globe Newswire 8:00 AM

-- August 10, 2026 --

Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models Globe Newswire 8:00 AM

-- June 15, 2026 --

Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensitivity with Telomir-Zn in a Preclinical Type 2 Diabetes Model ACCESS Newswire 8:00 AM

-- May 20, 2026 --

Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease ACCESS Newswire 8:00 AM

-- April 30, 2026 --

Telomir Pharmaceuticals Announces FDA Clearance of IND for Telomir-Zn in Triple-Negative Breast Cancer ACCESS Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software